Banner & Witcoff, Ltd.
Established In 1920 - Predecessor Parent
Size of Organization: 86 Year Established: 1920 Web Site: http://www.bannerwitcoff.com
Telephone: 202-824-3000
Facsimile: 202-824-3001
| |
Profile Visibility 
#1,828 in weekly profile views out of 270,734 total law firms Overall |
|
|
|
|
| Patent, Trademark, Copyright and Unfair Competition | Trademark, Copyright, and Unfair Competition |
|
|
Learn More |
Banner & Witcoff, Ltd. is dedicated to the practice of intellectual property law. The firm provides legal representation in obtaining, commercializing and litigating intellectual property rights in the United States and abroad. The practice includes counseling on the availability, validity and enforcement of intellectual property rights; patent interference proceedings; trademark opposition and cancellation proceedings; domestic and foreign patent and trademark prosecution; custom seizures of infringing products; and litigating patent, trademark and copyright infringement cases. Firm members have experience in both jury and bench trials in the Federal Courts and in proceedings before the International Trade Commission. Firm attorneys practice in all technologies, including the electrical, mechanical and chemical arts as well as computer hardware and software, internet and e-commerce, and biotechnology.
Martindale-Hubbell has augmented a firm's provided information with third-party sourced data to present a more comprehensive overview of the firm's expertise:
U.S. Federal Litigation Activity
Highest number of cases by Banner & Witcoff, Ltd.:
Intellectual Property (66 cases in past two years)
U.S. Patent Activity
Total number of U.S. granted patents by Banner & Witcoff, Ltd.:
2578 (in past two years)
Peer Review Ratings
Total number of Peer Review Rated lawyers of Banner & Witcoff, Ltd.:
21
Documents by Banner & Witcoff, Ltd. on Martindale.com
| |
Supreme Court Decides Bowman v. MonsantoSarah A. Kagan, May 17, 2013
The Supreme Court handed down a unanimous decision today in Bowman v. Monsanto, holding the doctrine of patent exhaustion does not permit a farmer to reproduce patented seeds by replanting seeds after growing a first crop.
Supreme Court to Weigh In on Gene PatentsPaul M. Rivard, April 18, 2013
On April 15, 2013, the U.S. Supreme Court heard arguments in Association for Molecular Pathology (AMP) v. Myriad Genetics, Inc. At issue is the eligibility of Myriad’s patent claims to isolated DNA encoding BRCA1 polypeptides. Individuals who inherit a mutatedBRCA1 gene have an increased...